Evolution of Our Understanding of XIAP Deficiency
X-linked inhibitor of apoptosis (XIAP) deficiency is a rare inborn error of immunity first described in 2006. XIAP deficiency is characterised by immune dysregulation and a broad spectrum of clinical manifestations, including haemophagocytic lymphohistiocytosis (HLH), inflammatory bowel disease (IBD...
Main Authors: | Anne C. A. Mudde, Claire Booth, Rebecca A. Marsh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2021.660520/full |
Similar Items
-
Systemic Epstein–Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants
by: Masataka Ishimura, et al.
Published: (2019-05-01) -
Haemophagocytic Lymphohistiocytosis with Lung Cavity and Lytic Bone Lesion in A 45 Day Infant
by: Sanjay A Natu, et al.
Published: (2014-03-01) -
Haematopoietic Stem Cell Transplantation for Primary Haemophagocytic Lymphohistiocytosis
by: Kai Lehmberg, et al.
Published: (2019-10-01) -
Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
by: Rebecca A. Marsh
Published: (2018-01-01) -
Síndromes hemofagocíticos: la importancia del diagnóstico y tratamiento precoces
by: Itziar Astigarraga, et al.
Published: (2018-08-01)